Market Overview:

Southern blotting is a technique in molecular biology used to detect specific DNA or RNA sequences in samples like genomic DNA. It is commonly used in gene mapping, DNA fingerprinting, and the study of gene expression. The technique involves restriction enzyme digestion of DNA, agarose gel electrophoresis, transferring DNA from the gel to a membrane, hybridizing a probe to the target sequence, and detecting the probe through autoradiography or chemiluminescence. These steps allow researchers to detect specific nucleic acid sequences in samples and analyze genetic material.

The global Southern Blotting Market is estimated to be valued at US$ 2.8 Bn in 2023 and is expected to exhibit a CAGR of 5.2% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.


Market Dynamics:

The growth of the Southern blotting market is driven by increasing research on genomics and proteomics across pharmaceutical and biotechnology companies. Growing applications of the technique in medical diagnostics, disease research, and forensic analysis also contribute to market growth. For instance, Southern blotting is used to study genomic imprinting and chromosome mapping that has implications in diagnosing genetic disorders. Additionally, growing focus on precision medicine spurs research in targeted therapeutics, further fueling adoption of techniques like Southern blotting. However, availability of alternative techniques like PCR and sequencing hamper market growth to some extent.

SWOT Analysis

Strength: Southern Blotting allows researchers to study gene expression and identification of genes simultaneously. It provides high specificity and sensitivity to detect DNA/RNA fragments. The technique has a long shelf life and straightforward protocol.

Weakness: Southern Blotting is a time-consuming process that takes around 2-3 days for completion. It requires large quantities of DNA or RNA for analysis.

Opportunity: Growing R&D investments in genomics and drug discovery areas offer lucrative opportunities for market growth. Increasing demand for personalized medicine also promotes the adoption of Southern Blotting technique.

Threats: Availability of alternative techniques like PCR and microarrays that provide faster results pose serious threats. High costs associated with Southern Blotting instruments limit its adoption.

Key Takeaways

 
The global Southern Blotting Market Growth is expected to witness high growth, exhibiting CAGR of 5.2% over the forecast period, due to increasing R&D investments in genomics and drug discovery. Large biomolecule researchers are widely relying on Southern Blotting for gene identification and expression analysis.

Regional analysis:

North America dominated the Southern Blotting market in 2021 with largest market share owing to presence of leading lifescience research companies and availability of advanced research infrastructure. Asia Pacific is expected to be the fastest growing region on account of rising R&D investments by both public and private sectors in India and China.

Key players operating in the Southern Blotting market are Thermo Fisher Scientific, Merck KGaA, Danaher Corporation, Agilent Technologies, PerkinElmer, GE Healthcare, Promega Corporation, Genetec, Bio-Rad Laboratories, Abcam. These companies are focusing on new product launch and expansion strategies to strengthen their foothold.

For more details on the report,  Read- https://dailynewsmotion.weebly.com/report-blog/southern-blotting-is-estimated-to-witness-high-growth-owing-to-increasing-research-on-genomics-and-proteomics